Monthly cost and long-term medication economic analysis of canafenib/encofenib

Canafenib/Encorafenib (Encorafenib) is a BRAF inhibitor, mainly used to treat advanced or metastatic melanoma and other related tumors carrying BRAF V600 mutations. Due to its targeted therapeutic properties, it can effectively block tumor signaling pathways and delay disease progression. However, as a newly launched drug, the supply of canafenib in the domestic market is relatively limited, and patients have certain difficulties in obtaining the drug. They need to consult regular hospital pharmacies for specific purchase channels and prices.

From a price point of view, Canafenib is priced higher in overseas markets, especially the European version. 75mg×42The price of each box can reach more than 10,000 yuan, and the price of 75mg×168 tablets may exceed 40,000 yuan. If it is taken once a day or as prescribed by a doctor for a long time, the cost of medication for one month is very high, which is a large financial burden for most patients. Therefore, when choosing a medication plan, financial affordability needs to be considered comprehensively.

In order to reduce medication costs, some patients may choose the Lao version of the generic version of canafenib. The composition of this version of the drug is basically the same as that of the original drug, and the price per box is about 4,000 yuan, which has a clear price advantage over the original drug. By obtaining generic drugs through legal channels, patients can significantly reduce their monthly medication expenses while ensuring the efficacy, thereby achieving economic sustainability.

Generally speaking, the long-term medication of canafenib has great economic pressure, especially because the original drug is expensive. When patients make medication decisions, they should consider medical insurance policies, drug procurement channels, and personal economic conditions to rationally choose drug versions. At the same time, combined medication or alternative treatment options can be discussed with the doctor to optimize the treatment effect and economic cost and ensure the feasibility and safety of long-term treatment.

Reference materials:https://www.drugs.com/